{
  "id": 4652954,
  "title": "Identification of miR-615-5p/ID1 axis crucial in the pathogenesis of pancreatic ductal adenocarcinoma (PDAC)",
  "url": "https://urgent.news/2026/08/31/identification-of-mir-615-5p-id1-axis-crucial-in-the-pathogenesis-of",
  "topic": "science",
  "section": "Science",
  "published": "2026-08-31T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.08.27.747461v1?rss=1"
  },
  "original_language": "en",
  "account": "Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of cancer with high metastasis rates, resistance to treatment, and poor prognosis. The protein Inhibitor of differentiation 1 (ID1) is often overexpressed in PDAC and linked to tumor growth and unfavorable patient outcomes. However, the exact ways in which ID1 is regulated post-transcriptionally are not well understood. Researchers have now identified a new regulatory mechanism involving a small molecule called miR-615-5p and ID1 in the context of PDAC.\n\nUsing a computer program to predict potential targets, miR-615-5p was identified as a significant regulator of ID1 expression in PDAC cases. When researchers examined clinical data from PDAC patients, they found that lower levels of miR-615-5p were associated with higher levels of ID1. This relationship was confirmed in laboratory tests where miR-615-5p was shown to suppress the expression of ID1 through a specific binding site.\n\nFurther experiments demonstrated that both miR-615-5p and ID1 interact with a protein called AGO2, which is part of a complex known as RISC (RNA-induced silencing complex). When AntimiR, a substance that inhibits miRNA function, was used to block miR-615-5p, the association between miR-615-5p and ID1 with AGO2 was disrupted. This supports the idea that miR-615-5p and ID1 have a specific interaction.\n\nThe researchers also discovered that the miR-615-5p/ID1 axis had an impact on a cellular process called autophagy, which is involved in cell survival and degradation. MiR-615-5p appears to inhibit autophagy, which in turn suppresses ID1-driven cellular migration. This suggests that the suppression of miR-615-5p leads to increased ID1 expression, promoting poor clinical outcomes in PDAC cells.\n\nOverall, this study sheds light on a previously unknown post-transcriptional regulation of ID1 in PDAC and highlights the role of the miR-615-5p/ID1 axis in autophagy-associated migratory responses. Understanding this mechanism may provide new insights into the development of potential therapeutic strategies for treating PDAC.",
  "summary": "Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by high metastatic dissemination, therapy resistance, and poor clinical outcome. Inhibitor of differentiation 1 or ID1, is frequently overexpressed in PDAC and is associated with tumour progression and adverse clinical outcome. However, the mechanisms governing its post-transcriptional regulation remain…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}